Adjuvant endocrine therapy in premenopausal women with breast cancer.
González Martín
Antonio
A
Department of Medical Oncology, Centro Oncológico MD Anderson International España, Calle Arturo Soria 270, 28033 Madrid, Spain. agonzalezm@mdanderson.es
de la Cruz
Susana
S
Márquez
Raúl
R
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006801:Humans; D010053:Ovary / Q000187:drug effects / Q000378:metabolism; D017697:Premenopause; D011960:Receptors, Estrogen / Q000037:antagonists & inhibitors; D016019:Survival Analysis; D013629:Tamoxifen / Q000627:therapeutic use; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D011960:Receptors, Estrogen; D013629:Tamoxifen; D007987:Gonadotropin-Releasing Hormone